MRKR — Marker Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00- $13.13m
- -$6.07m
- $6.59m
- 20
- 48
- 12
- 15
Annual balance sheet for Marker Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 21.4 | 42.4 | 11.8 | 15.1 | 19.2 |
| Net Total Receivables | 1 | 0 | 2.4 | 1.03 | 2.35 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 24.4 | 46 | 16.6 | 17.1 | 22 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 21.2 | 22.2 | 17.8 | — | — |
| Other Long Term Assets | |||||
| Total Assets | 45.6 | 68.1 | 34.4 | 17.1 | 22 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 6.4 | 12.9 | 7.78 | 3.07 | 3.46 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 18.3 | 24.1 | 14.8 | 3.07 | 3.46 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 27.3 | 44 | 19.6 | 14.1 | 18.6 |
| Total Liabilities & Shareholders' Equity | 45.6 | 68.1 | 34.4 | 17.1 | 22 |
| Total Common Shares Outstanding |